Literature DB >> 22328174

Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories.

Shashirekha Shetty1, Marion Siady, Kalyan C Mallempati, Andrew Wilson, Jeff Poarch, Brandon Chandler, Judy Gray, Mohamed E Salama.   

Abstract

Targeted FISH analysis is an essential component of the management of plasma cell myeloma for identification of cytogenetic abnormalities. The purpose of this study was to evaluate the column-free method, RoboSep® (RS), for sorting CD138-expressing cells in bone marrow aspirates. Comparative analysis of column-based and RS methodologies was carried out on 54 paired bone marrow aspirate validation samples from patients undergoing work-up for plasma cell dyscrasia. Abnormalities detected by FISH analysis using an IGH@/CCND1 probe set were seen in 54% with RS, and 44% with column-based. We found a statistically significant difference between the yield of abnormalities detected in paired positive cases (p = 0.0001). An additional 183 consecutive post-validation samples sorted by RS showed recurrent genetic abnormalities in 85/120 (71%) of successfully sorted samples with ≥ 1% plasma cells but in none of 63 samples in which FISH analysis was completed on samples that could not be sorted due to insufficient plasma cells upon cell sorting. The column-free method successfully sorted PC, when present in ≥ 1% of cells, for detection of abnormalities by FISH. Furthermore, our data suggest that FISH analysis should not be performed on samples with an inadequate yield at the cell selection step.

Entities:  

Mesh:

Year:  2012        PMID: 22328174     DOI: 10.1007/s12185-012-1021-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  The role of cytogenetics in myeloma.

Authors:  F Zhan; J Sawyer; G Tricot
Journal:  Leukemia       Date:  2006-09       Impact factor: 11.528

2.  Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

Authors:  Hervé Avet-Loiseau; Michel Attal; Philippe Moreau; Catherine Charbonnel; Frédéric Garban; Cyrille Hulin; Serge Leyvraz; Mauricette Michallet; Ibrahim Yakoub-Agha; Laurent Garderet; Gérald Marit; Lucienne Michaux; Laurent Voillat; Marc Renaud; Bernard Grosbois; Gaelle Guillerm; Lotfi Benboubker; Mathieu Monconduit; Catherine Thieblemont; Philippe Casassus; Denis Caillot; Anne-Marie Stoppa; Jean-Jacques Sotto; Marc Wetterwald; Charles Dumontet; Jean-Gabriel Fuzibet; Isabelle Azais; Véronique Dorvaux; Marc Zandecki; Régis Bataille; Stéphane Minvielle; Jean-Luc Harousseau; Thierry Facon; Claire Mathiot
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

3.  Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.

Authors:  Samer Z Al-Quran; Lijun Yang; James M Magill; Raul C Braylan; Vonda K Douglas-Nikitin
Journal:  Hum Pathol       Date:  2007-08-21       Impact factor: 3.466

4.  Metaphase cytogenetic techniques in multiple myeloma.

Authors:  Jeffrey R Sawyer
Journal:  Methods Mol Biol       Date:  2011

5.  Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

Authors:  Nikhil C Munshi; Kenneth C Anderson; P Leif Bergsagel; John Shaughnessy; Antonio Palumbo; Brian Durie; Rafael Fonseca; A Keith Stewart; Jean-Luc Harousseau; Meletios Dimopoulos; Sundar Jagannath; Roman Hajek; Orhan Sezer; Robert Kyle; Pieter Sonneveld; Michele Cavo; S Vincent Rajkumar; Jesus San Miguel; John Crowley; Hervé Avet-Loiseau
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

6.  Four-color flow cytometric analysis of myeloma plasma cells.

Authors:  Shoichi Kobayashi; Rie Hyo; Yukiko Amitani; Masatsugu Tanaka; Chizuko Hashimoto; Rika Sakai; Takeshi Tamura; Shigeki Motomura; Atsuo Maruta
Journal:  Am J Clin Pathol       Date:  2006-12       Impact factor: 2.493

7.  Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting.

Authors:  Jana Cumova; L Kovarova; A Potacova; I Buresova; F Kryukov; M Penka; J Michalek; R Hajek
Journal:  Int J Hematol       Date:  2010-08-07       Impact factor: 2.490

Review 8.  Chromosome translocations in multiple myeloma.

Authors:  P L Bergsagel; W M Kuehl
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

9.  Clinical and biologic implications of recurrent genomic aberrations in myeloma.

Authors:  Rafael Fonseca; Emily Blood; Montserrat Rue; David Harrington; Martin M Oken; Robert A Kyle; Gordon W Dewald; Brian Van Ness; Scott A Van Wier; Kimberly J Henderson; Richard J Bailey; Philip R Greipp
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

Review 10.  International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Authors:  R Fonseca; P L Bergsagel; J Drach; J Shaughnessy; N Gutierrez; A K Stewart; G Morgan; B Van Ness; M Chesi; S Minvielle; A Neri; B Barlogie; W M Kuehl; P Liebisch; F Davies; S Chen-Kiang; B G M Durie; R Carrasco; Orhan Sezer; Tony Reiman; Linda Pilarski; H Avet-Loiseau
Journal:  Leukemia       Date:  2009-10-01       Impact factor: 11.528

View more
  4 in total

Review 1.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

2.  The colorful landscape of multiple myeloma.

Authors:  Eli Muchtar; Morie A Gertz
Journal:  Leuk Lymphoma       Date:  2019-02-27

3.  Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.

Authors:  Mohamed E Salama; Shouying Du; Olga Efimova; Nahla M Heikal; Erik Wendlandt; Reha M Toydemir; Sarah South; Sherrie L Perkins; Jerry W Hussong; Fenghuang Zhan
Journal:  Leuk Lymphoma       Date:  2014-08-04

4.  Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases

Authors:  Vishal Ashok; Ramya Ranganathan; Smitha Chander; Sharat Damodar; Sunil Bhat; Nataraj K S; Satish Kumar A; Sachin Suresh Jadav; Mahesh Rajashekaraiah; Sundareshan T S
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.